Johan Rönnelid (J Rönnelid)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Topics

Rheumatoid Arthritis

Pulmonary Fibrosis

Top Venues

Annals of the rheumatic diseases

Arthritis & rheumatology (Hoboken, N.J.)

Rheumatology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Tomas Weitoft, Johan Rönnelid, Anders Lind, Charlotte de Vries, Anders O Larsson, Barbara Potempa, Jan Potempa, Alf Kastbom, Klara Martinsson, Karin Lundberg, Marieann Högman
Exhaled Nitric Oxide Reflects the Immune Reactions of the Airways in Early Rheumatoid Arthritis. Biomedicines 12 (5) (2024)
Tomas Weitoft, Johan Rönnelid, Anders Lind, Charlotte de Vries, Anders O Larsson, Barbara Potempa, Jan Potempa, Alf Kastbom, Klara Martinsson, Karin Lundberg, Marieann Högman
Exhaled Nitric Oxide Reflects the Immune Reactions of the Airways in Early Rheumatoid Arthritis. Biomedicines 12 (5) (2024)
Eleftheria Pertsinidou, Saedis Saevarsdottir, Vivek Anand Manivel, Lars Klareskog, Lars Alfredsson, Linda Mathsson-Alm, Monika Hansson, Martin Cornillet Jeannin, Guy Serre, Rickard Holmdahl, Karl Skriner, Per-Johan Jakobsson, Helga Westerlind, Johan Askling, Johan Rönnelid
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation. Annals of the rheumatic diseases (2023)
Sandra Selickaja, Angeles Shunashy Galindo-Feria, Lara Dani, Tsuneyo Mimori, Johan Rönnelid, Marie Holmqvist, Ingrid E Lundberg, Paulius Venalis
ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis. Rheumatology (Oxford, England) 61 (12) (2022)
Tomas Weitoft, Anders Lind, Anders O Larsson, Johan Rönnelid, Marieann Högman
Exhaled nitric oxide in early rheumatoid arthritis and effects of methotrexate treatment. Scientific reports 12 (1) (2022)
Klara Martinsson, Lovisa Lyttbacka Kling, Karin Roos-Ljungberg, Irina Griazeva, Marina Samoylovich, Stephane Paul, Johan Rönnelid, Tomas Weitoft, Jonas Wetterö, Alf Kastbom
Extramucosal Formation and Prognostic Value of Secretory Antibodies in Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.) 74 (5) (2022)
Awais Ahmad, Charlotte Dahle, Johan Rönnelid, Christopher Sjöwall, Stergios Kechagias
Autoantibodies Associated with Autoimmune Liver Diseases in a Healthy Population: Evaluation of a Commercial Immunoblot Test. Diagnostics (Basel, Switzerland) 12 (7) (2022)
Mikael Brink, Lotta Ljung, Monika Hansson, Johan Rönnelid, Rickard Holmdahl, Karl Skriner, Guy Serre, Lars Klareskog, Solbritt Rantapää Dahlqvist
Anti-citrullinated protein antibody specificities and pulmonary fibrosis in relation to genetic loci in early rheumatoid arthritis. Rheumatology (Oxford, England) 61 (12) (2022)
N Sippl, F Faustini, Johan Rönnelid, Sara Turcinov, Karine Chemin, Iva Gunnarsson, Vivianne Malmström
Arthritis in systemic lupus erythematosus is characterized by local IL-17A and IL-6 expression in synovial fluid. Clinical and experimental immunology 205 (1) (2021)
Johan Rönnelid, Örjan Dahlström, Charlotte Dahle, Christopher Sjöwall
Correspondence on 'Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities'. Annals of the rheumatic diseases (2020)
Helga Westerlind, Johan Rönnelid, Monika Hansson, Lars Alfredsson, Linda Mathsson-Alm, Guy Serre, Martin Cornillet, Rikard Holmdahl, Per-Johan Jakobsson, Karl Skriner, Lars Klareskog, Saedis Saevarsdottir, Johan Askling
Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.) 72 (10) (2020)
Amir I Elshafie, Sahwa Elbagir, Mawahib I E Aledrissy, Elnour M Elagib, Musa A M Nur, Johan Rönnelid
Occurrence of anti-CCP2 and RF isotypes and their relation to age and disease severity among Sudanese patients with rheumatoid arthritis. Clinical rheumatology 38 (6) (2019)
Antonia Boman, Mikael Brink, Anders Lundquist, Monica Hansson, Linda Mathsson-Alm, Johan Rönnelid, Ewa Berglin, Rickard Holmdahl, Karl Skriner, Guy Serre, Lars Klareskog, Solbritt Rantapää Dahlqvist
Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study. RMD open 5 (2) (2019)
Azita Sohrabian, Ioannis Parodis, Nellie Carlströmer-Berthén, Martina Frodlund, Andreas Jönsen, Agneta Zickert, Christopher Sjöwall, Anders A Bengtsson, Iva Gunnarsson, Johan Rönnelid
Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus. Arthritis research & therapy 21 (1) (2019)
Johan Rönnelid, Hector Fabricio Espinosa-Ortega, Ingrid E Lundberg
Response to: 'Semi-quantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance?' by Cavazzana et al. Annals of the rheumatic diseases 79 (11) (2019)
Johan Rönnelid, Hector Fabricio Espinosa-Ortega, Ingrid E Lundberg
Response to: 'Comment on: standardisation of myositis-specific antibodies: where are we today?' by Infantino et al. Annals of the rheumatic diseases 80 (7) (2019)
Bernard J Fox, Jason Hockley, Peter Rigsby, Carl Dolman, Pier Luigi Meroni, Johan Rönnelid
A WHO Reference Reagent for lupus (anti-dsDNA) antibodies: international collaborative study to evaluate a candidate preparation. Annals of the rheumatic diseases 78 (12) (2019)